For research purposes only. Not for human consumption. For use by licensed researchers only.
Ipamorelin is a selective growth hormone secretagogue and ghrelin receptor agonist composed of five amino acids. It is among the most studied growth hormone-releasing peptides (GHRPs) due to its high selectivity and minimal off-target endocrine effects compared to earlier generation GHRPs.
Mechanism of Action
Ipamorelin stimulates growth hormone release from the anterior pituitary by binding to the ghrelin receptor (GHS-R1a), without significantly elevating cortisol, prolactin, or aldosterone. Research indicates it selectively amplifies the natural pulsatile release of GH, making it a precise tool for studying GH axis regulation.
Research Applications
- Growth hormone secretion and pulsatility research
- Pituitary gland function and GH axis studies
- Muscle mass and protein synthesis models
- Body composition and fat metabolism research
- Anti-aging and longevity pathway investigation
Research Grade Peptide
| Compound | Ipamorelin (Pentapeptide GHRP) |
| Strength | 10 mg |
| Vial Size | 3 mL |
| Vial Color | Clear |
| Form | Lyophilized Powder |
| Purity | >98% (HPLC verified) |
| Price | $80.00 |
This compound is provided strictly for in vitro and laboratory research. It has not been evaluated by the FDA and is not intended for diagnostic, therapeutic, or human use. Available to licensed researchers only.